FindTrial
Sign In

A collaborative HCV cascade module of care in Hemophilia clinics in China in collaboration with National Hemophilia Organization

A collaborative HCV cascade module of care in Hemophilia clinics in China in collaboration with National Hemophilia Organization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027288
Enrollment
Unknown
Registered
2019-11-07
Start date
2020-05-10
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C

Interventions

Case series:HCV screening

Sponsors

Jumei Foundation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All haemophilia patients aged >=18 years, registered in 15 selected clinics of blood friend's family; 2. Patient is able to give written informed consent prior to study start and to comply.

Exclusion criteria

Exclusion criteria: Patient is not able to give written informed consent prior to study start and to comply.

Design outcomes

Primary

MeasureTime frame
anti-HCV;—

Countries

China

Contacts

Public ContactYongqian Cheng

Beijing Changfeng Hospital

chengyq302@126.com+86 18612202563

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026